ArticleCell death & disease2024

Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer's disease mice by controlling astrocyte activation.

Akira Sobue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.